Pharmaceutical Industry

Page 64 of 100

Sanders Joins Clinton At Campaign Event In Portsmouth
Health

Bernie Sanders Butts Heads with Cancer Drug Maker over a Huge Price Hike

By
October 21, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health

Why These Copycat Drugs Aren’t Slashing Best-Sellers’ Prices

By
October 18, 2016
How Valeant Is Justifying Its New Kinder, Gentler Drug Price Hikes
Health

How Valeant Is Justifying Its New Kinder, Gentler Drug Price Hikes

By
October 17, 2016
Mother sleeping with newborn baby on bed
Health

Homeopathic Treatments May Have Led to Deaths in Teething Babies

By
October 12, 2016
Novo Nordisk Chief Executive Officer Lars Soerensen Interview
Leadership

This Big Pharma Chief Was Just Named the World’s ‘Best-Performing’ CEO—Again

By
October 12, 2016
Cancer Consulting Elderly Person
Health

Why Pharma Giant Bristol-Myers Squibb’s Shares Took a Big Hit Today

By
October 10, 2016
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health

The FDA’s Most Controversial Drug Approval of the Year Just Hit a Huge Snag

By
October 7, 2016
Alnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
Health

Alnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths

By
October 6, 2016
Mylan CEO Heather Bresch Testifies On EpiPen Price Increases Before The House Oversight And Government Reform Committee
Health

Government Health Plans Spent Over $1 Billion on Mylan EpiPens Over 5 Years

By Fortune Editors and Reuters and Michelle Toh
October 6, 2016
CIO, 2 Others To Resign After JPMorgan Chase $2 Billion Trading Error
Retail

JPMorgan Is Pulling Chase ATMs from Walgreens Stores

By Reuters and Michelle Toh
October 4, 2016
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
Health

Samsung’s Biotech Unit Is Seeking Europe Approval for Its Copy of This Drug

By Reuters and Michelle Toh
October 4, 2016
House Oversight Committee Holds Hearing On Rising Price Of EpiPens With Mylan Inc. CEO Heather Bresch
Health

More and More Americans Think Prescription Drug Costs Are ‘Unreasonable’

By
September 29, 2016
U.S. company stock buybacks are down 21 percent in the first seven months of 2016.
Health

Why Intra-Cellular Therapies’ Stock Got Crushed Today

By
September 29, 2016
Shelley Ewalt
Retail

Target Pharmacy Customers Are Not Happy With Their New CVS Pill Bottles

By
September 29, 2016
House Oversight Hearing On Prescription Drug Price Increases
Leadership

Martin Shkreli Is Auctioning Off a Chance to Punch Him in the Face

By Megan McCluskey, TIME and Michelle Toh
September 28, 2016

Most Popular